David Roberge

David Roberge is a Clinical Professor at the Université de Montréal's Faculty of Medicine, part of the Department of Radiology, Radiation Oncology, and Nuclear Medicine. He is affiliated with the CRCHUM research center and the Centre Hospitalier de l'Université de Montréal (CHUM). His clinical and research expertise focuses on advanced radiotherapy techniques, including stereotactic radiosurgery, extracranial radiosurgery, and neuro-oncology applications. Dr. Roberge leads and participates in major clinical trials, such as the NRG Oncology CC001 trial evaluating hippocampal-sparing radiotherapy for brain metastases. He has received funding for innovative projects like the Onco-Tech initiative, which explores novel oncology technologies. His work spans translational research, clinical outcomes analysis, and multidisciplinary patient care. Awards include the Onco-Tech grant (2019). Key collaborations include McGill University, MITACS, and the Radiation Therapy Oncology Group (RTOG).

Research interests include technical advancements in radiotherapy, clinical trial design, and outcomes in neuro-oncology. He co-authored high-impact studies on brain metastasis management, cognitive preservation during radiation therapy, and palliative care for hepatocellular carcinoma. Dr. Roberge's contributions bridge clinical practice and cutting-edge technologies, emphasizing personalized treatment approaches.